• Vanessa Acquaah (chair)

• Caitlin Clunie-O’Connor (programme

  manager)

• Victor Lhoste (Lead Methodologist)

• Daissy Chica (Partnership Lead)

• Jennifer McCaffery (lay), Kaeden Bunting (lay)

• Thomas Smith (patient)

• Trishna Bharadia (patient)

• Yanrong Jiang (clinical)

• Yasmin Hassen (Research Lead/Surgeon) 

No conflicts declared by panel

Approved

• The lay summary was well-written, providing a clear, easily understandable overview of Invasive Lobular Carcinoma (ILC) and the rationale behind the study.

• The aims and objectives were clearly outlined, making it very easy to see the tangible benefits of the study.

• The project shows a clear benefit to the community, especially in its potential to support more accurate predictions of recurrence for ILC patients.
• The proposal effectively demonstrated that Real-World Data (RWD) can provide vital insights into current clinical practices.
• The panel raised several comments on other aspects of the application including:
   
  • • Further clarification regarding the treatments available to ILC patients and how this will inform the inclusion and exclusion criteria.
    • The panel inquired about the methodology that will be used for patient stratification.
    • The group discussed the study's potential to shape national guidelines in the future.

    • The panel discussed approaches to sharing findings with patients on a national level.